Cardano Risk Management B.V. purchased a new position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 535,748 shares of the semiconductor company's stock, valued at approximately $232,156,000. Lam Research makes up 1.8% of Cardano Risk Management B.V.'s portfolio, making the stock its 16th largest position.
A number of other hedge funds have also added to or reduced their stakes in LRCX. Bayban bought a new stake in Lam Research during the fourth quarter worth $26,000. Vermillion Wealth Management Inc. bought a new position in shares of Lam Research in the 1st quarter valued at $26,000. Cedar Mountain Advisors LLC increased its stake in shares of Lam Research by 242.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after purchasing an additional 85 shares during the last quarter. Mcguire Capital Advisors Inc. acquired a new position in shares of Lam Research during the 4th quarter worth $27,000. Finally, Triumph Capital Management acquired a new position in shares of Lam Research during the 3rd quarter worth $27,000. 84.61% of the stock is owned by institutional investors.
Lam Research Stock Performance
Shares of LRCX stock opened at $311.35 on Friday. Lam Research Corporation has a one year low of $94.11 and a one year high of $438.50. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The business's 50 day simple moving average is $339.89 and its 200 day simple moving average is $279.64. The stock has a market capitalization of $389.36 billion, a PE ratio of 54.05, a PEG ratio of 1.25 and a beta of 1.84.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping analysts' consensus estimates of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. Lam Research's quarterly revenue was up 30.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, research analysts forecast that Lam Research Corporation will post 9.24 earnings per share for the current year.
Lam Research Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 8th. Stockholders of record on Wednesday, June 17th were paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Wednesday, June 17th. Lam Research's payout ratio is currently 18.06%.
Insider Activity
In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the company's stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director owned 87,142 shares in the company, valued at $29,192,570. This represents a 17.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the firm's stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the sale, the senior vice president directly owned 58,470 shares of the company's stock, valued at $18,102,312. This represents a 11.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 80,441 shares of company stock valued at $27,614,296 in the last ninety days. 0.31% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on LRCX shares. Cantor Fitzgerald set a $500.00 price objective on Lam Research and gave the company an "overweight" rating in a research note on Monday, June 29th. Citigroup reissued a "buy" rating and set a $450.00 target price (up from $315.00) on shares of Lam Research in a research note on Wednesday, June 17th. Rothschild & Co Redburn raised their price target on shares of Lam Research from $305.00 to $420.00 and gave the company a "buy" rating in a research note on Wednesday, June 17th. Raymond James Financial set a $425.00 price target on shares of Lam Research in a research note on Wednesday, June 10th. Finally, TD Cowen reiterated a "buy" rating and set a $400.00 price objective (up from $340.00) on shares of Lam Research in a research report on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Lam Research currently has an average rating of "Moderate Buy" and a consensus target price of $358.47.
Read Our Latest Stock Report on Lam Research
About Lam Research
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.